Improving the Way People See the World
Alcon has one vision: to improve quality of life around the world by helping people see better. Healthcare professionals, patients and their families rely on us to discover, develop and produce the very best in innovative eye care products.
Leading the Fight Against Glaucoma
Glaucoma is a leading cause of blindness, and it affects about 3 million Americans. That's why glaucoma is a focal point for Alcon. Our leadership in this area continues with the EX-PRESS® Glaucoma Filtration Device, and we're proud to be at the forefront of medicinal and surgical treatments for glaucoma patients.
Our commitment to research and development fuels our ability to consistently deliver best-in-class surgical, pharmaceutical and consumer eye care products.
Glaucoma Progression and Treatment
Once diagnosed, primary open-angle glaucoma can, in most cases, be managed through the long-term use of eye drops to reduce intraocular pressure. Some patients may also undergo laser procedures to treat their glaucoma. However, when medication and laser treatments don't provide the desired results, surgery may be the only option for effectively reducing IOP.
As glaucoma treatment progresses, patients' options narrow. But as glaucoma research continues, so do advancements in treatment. The standard filtration surgery — the trabeculectomy — hasn't seen a significant update since the 1960s, opening the door for the EX-PRESS® Glaucoma Filtration Device to significantly advance glaucoma filtration surgery.
|Prostaglandin Agonists||Selective Laser Trabeculoplasty||EX-PRESS® Glaucoma Filtration Device||Valved|
|Beta Blockers||Argon Laser Trabeculoplasty||Trabeculectomy||Non-valved|
|Carbonic Anhydrase Inhibitors||Micro-Invasive Glaucoma Surgery|
Enjoy the Benefits of Lumenal Control
Sign up and we’ll contact you right away with more information about the EX-PRESS® Glaucoma Filtration Device and other Alcon products.